The privately held biotech brings a first-in-class oncology program focused on small molecule–targeted protein degradation
Leaders from science, policy, industry, and investment came together in New Delhi to examine how alignment across the biotechnology value chain can turn innovation into outcomes at scale
Biotium reports that GlycoLiner Labelling is fully covalent and compatible with standard fixation and permeabilization protocols
INOVIO remains confident in the therapy’s benefits and intends to meet with the FDA to discuss maintaining eligibility under this pathway
These observations are procedural in nature and the company does not anticipate any impact on supply of its commercial products
The update promises to revolutionize laboratory workflows by optimizing resources
The move strengthens GBL’s clinical-stage presence in the United States
The pharmaceutical giant now expects 2026 revenues to land between $59.5 billion and $62.5 billion
These building blocks are essential to modern therapeutics, including fast-growing GLP-1 treatments for weight loss and diabetes
The company has unveiled the results of pirtobrutinib from its BRUIN CLL-313 study
Subscribe To Our Newsletter & Stay Updated
